LEKTI downregulation is associated with multiple cancers, including non-melanoma skin cancer, head and neck squamous cell carcinoma, and esophageal cancer [7,12,28], and its overexpression has been shown to inhibit the Wnt/β-catenin pathway, reducing tumor cell proliferation and invasion [12]. This evidence concerns the gene SPINK5 and non-melanoma skin carcinoma.